Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and prelimin...
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
About this item
Full title
Author / Creator
Publisher
London: London : Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
London: London : Springer-Verlag
Subjects
More information
Scope and Contents
Contents
This study assessed the safety and preliminary efficacy of the interleukin-1 receptor antagonist anakinra in patients with polyarticular-course juvenile rheumatoid arthritis (JRA). Eighty-six patients entered a 12-week open-label run-in phase (1 mg/kg anakinra daily, <=100 mg/day). Fifty responders were randomized to anakinra or placebo in a 16-wee...
Alternative Titles
Full title
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_881381820
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_881381820
Other Identifiers
ISSN
0770-3198
E-ISSN
1434-9949
DOI
10.1007/s10067-008-0995-9
